Abstract:Abstract: Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear receptor family. PPARs function as regulators of lipid and lipoprotein metabolism and glucose homeostasis and influence cellular proliferation, differentiation and apoptosis. PPARα is highly expressed in tissues such as liver, muscle, kidney and heart, where it stimulates the β-oxidative degradation of fatty acids. PPARγ is predominantly expressed in intestine and adipose tissue. PPARγ triggers adipocyte differentiation and promotes lipid storage. The hypolipidemic fibrates and the antidiabetic glitazones are synthetic ligands for PPARα and PPARγ, respectively. Furthermore, fatty acids and eicosanoids are natural PPAR ligands: PPARα is activated by leukotriene B4, whereas prostaglandin J2 is a PPARγ ligand. These observations suggested a potential role for PPARs not only in metabolic but also in inflammation control. The first evidence for a role of PPARα in inflammation control came from the demonstration that PPARα deficient mice display a prolonged response to inflammatory stimuli. It was suggested that PPARα deficiency results in a reduced β-oxidative degradation of these inflammatory fatty acid derivatives. More recently, PPAR activators were shown to inhibit the activation of inflammatory response genes (such as IL-2, IL-6, IL-8, TNFα and metalloproteases) by negatively interfering with the NF-κB, STAT and AP-1 signalling pathways. PPAR activators exert these anti-inflammatory activities in different immunological and vascular wall cell types such as monocyte/macrophages, endothelial, epithelial and smooth muscle cells in which PPARs are expressed. These recent findings indicate a modulatory role for PPARs in the control of the inflammatory response with potential therapeutic applications in inflammation-related diseases, such as atherosclerosis and inflammatory bowel disease.

Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer

Adipose Tissue-Specific PPARγ Deficiency Increases Resistance to Oxidative Stress

Peroxisomes and PPARs: Emerging role as master regulators of cancer metabolism

Peroxisome Proliferator-Activated Receptors: A Key Link Between Lipid Metabolism and Cancer Progression

Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth

Peroxisome Proliferator-Activated Receptor Γ and Colorectal Cancer.

The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies

PPAR-γ Modulators as Current and Potential Cancer Treatments

Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

Targeting Peroxisome Proliferator-Activated Receptor-β/δ, Reactive Oxygen Species and Redox Signaling with Phytocompounds for Cancer Therapy

New Insights into the Role of PPARγ in Skin Physiopathology

Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases

Progress of carcinogenesis and possible mechanisms of peroxisome proliferator-activated receptor agonists

Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy

PPARs as Nuclear Receptors for Nutrient and Energy Metabolism

PPAR Beta/Delta and the Hallmarks of Cancer

The Roles of PPARs in Human Diseases

PPAR-Mediated Toxicology and Applied Pharmacology

PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal-Epithelial Crosstalk and Carcinogenesis

Inhibition of Cancer Cell Proliferation by PPARγ is Mediated by a Metabolic Switch That Increases Reactive Oxygen Species Levels.

[Peroxisome Proliferator-Activated Receptors and Atherosclerosis].